Lab Central

Sanofi 2026 Golden Ticket

Who can apply: Open to biotechs developing advanced human-relevant disease modeling platforms that bridge the preclinical-to-clinical gap, with technologies of interest including organoids and organ-on-chip systems, AI/ML-enhanced predictive models, high-throughput screening platforms, computational biology tools, and biomaterial-based systems. Applications should demonstrate potential to improve target validation, predict therapeutic responses, enhance safety assessment, or enable precision medicine approaches across immunology, oncology, neurology, or ophthalmology.

Deadline: Applications are now being accepted; no specific deadline is stated on the page.

Biogen Golden Ticket

Who can apply: High-potential early-stage startups leveraging cutting-edge science to develop first-in-class, transformative medicines. Particular interest in neurology, immunology, nephrology, ophthalmology, rare diseases, tissue delivery, and target discovery innovations. Areas out of scope include oncology, infectious diseases, and vaccines.